Opus Capital Group, LLC Arch Therapeutics, Inc. Transaction History

Opus Capital Group, LLC

  • $800 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$0.09 - $0.12 $1,035 - $1,380
-11,500 Closed
0 $0
Q1 2021

Apr 28, 2021
BUY
$0.15 - $0.2 $1,725 - $2,300
11,500 New
11,500 $2,000

About Arch Therapeutics, Inc.

ARTH Quotes by TradingView
  • Ticker ARTH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,886,000
  • Market Cap $77.5M
  • Description
  • Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...
More about ARTH
Track This Portfolio

Track Opus Capital Group, LLC Portfolio

Follow Opus Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email